DCM
TRIL

DAFNA Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

DAFNA Capital Management’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-20,000
Closed -$88K – 85
2017
Q2 		$88K Buy
+20,000
New +$88K 0.06% 74